Back to Authors

Wong, Stephane

A5108432113 | I4210117619

Mayo Clinic

Novartis, Cambridge, MA;

Citations 2

Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7054-7054

10.1200/jco.2016.34.15_suppl.7054

Treatment-Free Remission After Second-Line Nilotinib Treatment in Patients With Chronic Myeloid Leukemia in Chronic Phase

Annals of Internal Medicine | February 19, 2018 | Volume: 168 | Issue: 7 | Pages: 461-470

10.7326/m17-1094 | PMID 29459949